181 related articles for article (PubMed ID: 10937845)
21. Looking into the eyes of patients with antiphospholipid syndrome.
Yehudai D; Shoenfeld Y; Toubi E
Clin Rev Allergy Immunol; 2007 Apr; 32(2):192-7. PubMed ID: 17916993
[TBL] [Abstract][Full Text] [Related]
22. Combined central retinal artery and vein occlusion associated with antiphospholipid syndrome.
Choudhary RA; Siddiqui MAR; Moiz B; Ishaq S
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35246439
[TBL] [Abstract][Full Text] [Related]
23. No excess of factor V:Q506 genotype but high prevalence of anticardiolipin antibodies without antiendothelial cell antibodies in retinal vein occlusion in young patients.
Scott JA; Arnold JJ; Currie JM; Broadfoot C; Davidson M; Kelly KF; Graham A; Kirkpatrick JN; Greaves M
Ophthalmologica; 2001; 215(3):217-21. PubMed ID: 11340395
[TBL] [Abstract][Full Text] [Related]
24. The clinico-ophthalmological spectrum of antiphospholipid syndrome.
Giorgi D; Gabrieli CB; Bonomo L
Ocul Immunol Inflamm; 1998 Dec; 6(4):269-73. PubMed ID: 9924923
[TBL] [Abstract][Full Text] [Related]
25. Ocular features associated with anticardiolipin antibodies: a descriptive study.
Miserocchi E; Baltatzis S; Foster CS
Am J Ophthalmol; 2001 Apr; 131(4):451-6. PubMed ID: 11292408
[TBL] [Abstract][Full Text] [Related]
26. Ocular manifestations in antiphospholipid syndrome.
Suvajac G; Stojanovich L; Milenkovich S
Autoimmun Rev; 2007 Jun; 6(6):409-14. PubMed ID: 17537387
[TBL] [Abstract][Full Text] [Related]
27. [Diagnosis of vascular occlusion of the posterior eye segment].
Prünte C; Gasser P
Klin Monbl Augenheilkd; 1993 May; 202(5):376-8. PubMed ID: 8377396
[TBL] [Abstract][Full Text] [Related]
28. [Vasoocclusive retinopathy in a patient with primary antiphospholipid syndrome].
Avetisov SE; Smirnova TV; Kozlovskaia NL; Kiseleva TN; Eliseeva EG; Budzinskaia MV; Murakhovskaia TV
Vestn Oftalmol; 2007; 123(3):46-8. PubMed ID: 17672096
[No Abstract] [Full Text] [Related]
29. [Bilateral sequential central retinal vein occlusion associated with primary antiphospholipid syndrome].
Querques L; Terrada C; Souied EH; Corrado A; Cantatore FP; Querques G
J Fr Ophtalmol; 2012 Jun; 35(6):443.e1-5. PubMed ID: 22463856
[TBL] [Abstract][Full Text] [Related]
30. Primary antiphospholipid antibody syndrome and retinal occlusive vasculopathy.
Wiechens B; Schröder JO; Pötzsch B; Rochels R
Am J Ophthalmol; 1997 Jun; 123(6):848-50. PubMed ID: 9535637
[TBL] [Abstract][Full Text] [Related]
31. Antiphospholipid antibody syndrome.
Yang P; Kruh JN; Foster CS
Curr Opin Ophthalmol; 2012 Nov; 23(6):528-32. PubMed ID: 23042148
[TBL] [Abstract][Full Text] [Related]
32. Ocular vaso-occlusive disease in primary antiphospholipid syndrome.
Castañón C; Amigo MC; Bañales JL; Nava A; Reyes PA
Ophthalmology; 1995 Feb; 102(2):256-62. PubMed ID: 7862414
[TBL] [Abstract][Full Text] [Related]
33. Combined central retinal vein and cilioretinal artery occlusion related to acute intra-ocular pressure rise of previously unknown pigment dispersion syndrome.
Martel A; Martiano D; Fisch AL; Pinon F; Baillif S
J Fr Ophtalmol; 2018 Apr; 41(4):e161-e164. PubMed ID: 29673629
[No Abstract] [Full Text] [Related]
34. Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases.
Carbone J; Sánchez-Ramón S; Cobo-Soriano R; Seoane E; Aparicio MJ; Ruiz-Tíscar JL; Rodríguez-Mahou M; Rodríguez-Molina JJ; Sarmiento E; Cortés C; Fernández-Cruz E
J Rheumatol; 2001 Nov; 28(11):2437-41. PubMed ID: 11708415
[TBL] [Abstract][Full Text] [Related]
35. Retinal vascular occlusion following ocular contusion.
Dalma-Weiszhausz J; Meza-de Regil A; Martínez-Jardón S; Oliver-Fernández K
Graefes Arch Clin Exp Ophthalmol; 2005 May; 243(5):406-9. PubMed ID: 15931542
[TBL] [Abstract][Full Text] [Related]
36. Antiphospholipid antibodies in ocular arterial and venous occlusive disease.
Palmowski-Wolfe AM; Denninger E; Geisel J; Pindur G; Ruprecht KW
Ophthalmologica; 2007; 221(1):41-6. PubMed ID: 17183200
[TBL] [Abstract][Full Text] [Related]
37. Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome.
Asherson RA; Merry P; Acheson JF; Harris EN; Hughes GR
Ann Rheum Dis; 1989 May; 48(5):358-61. PubMed ID: 2637678
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Dilemma in Sequential Branch Retinal Vein and Artery Occlusion.
Consigli A; Roquelaure D; Souteyrand G; Chizzolini C; Thumann G; Chronopoulos A
Optom Vis Sci; 2015 Nov; 92(11):e404-8. PubMed ID: 26421682
[TBL] [Abstract][Full Text] [Related]
39. Peripheral retinal neovascularization and retinal vascular occlusion associated with activated protein C resistance.
Greven CM; Wall AB
Am J Ophthalmol; 1997 Nov; 124(5):687-9. PubMed ID: 9372725
[TBL] [Abstract][Full Text] [Related]
40. [Antiphospholipid syndrome--interdisciplinary problem].
Wiszniewska M; Wiszniewski P; Hanszke E; Gaik I; Turowiecka Z
Pol Arch Med Wewn; 2006 May; 115(5):443-6. PubMed ID: 17195358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
